EHP Funds’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-10,673
Closed -$55.4K – 87
2025
Q3
$55.4K Buy
+10,673
New +$59.3K 0.05% 96

Other funds holding SLN

EHP Funds's SLN Position: Q4 2025 in Review

EHP Funds sold out of Silence Therapeutics (SLN) in Q4 2025, closing a stake of 10,673 shares — an estimated $55.4K sold.

EHP Funds first reported a position in SLN in Q3 2025 and held it in 1 quarter. The position peaked at $55.4K in Q3 2025. 58 funds tracked by Wall St. Rank hold SLN as of Q4 2025.

  • EHP Funds reported no remaining Silence Therapeutics position as of Q4 2025 after selling out during the quarter.
  • EHP Funds sold 10,673 Silence Therapeutics shares in Q4 2025, an estimated $55.4K.
  • EHP Funds first reported a position in Silence Therapeutics in Q3 2025 and held it in 1 quarter.
  • EHP Funds's Silence Therapeutics position peaked at $55.4K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Silence Therapeutics as of Q4 2025.

Based on EHP Funds's 13F filing for Q4 2025, filed 12 Feb 2026.